Carotid Atherosclerotic Plaque Study
NCT00214006 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 162
Last updated 2013-03-07
Summary
First, to establish a comparison of the pathophysiology of carotid atherosclerosis and the genetic and environmental variables that cause those plaques to become symptomatic. Second, to differentiate between vulnerable plaque and other types of plaque using ultrasound elastography, MRI data, trans-cranial doppler along with RF (radio frequency) analysis of back-scattered ultrasonic echoes.
Conditions
Sponsors & Collaborators
-
University of Wisconsin, Madison
lead OTHER
Principal Investigators
-
Robert J. Dempsey, MD · University of Wisconsin, Madison
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-11-30
- Primary Completion
- 2010-11-30
- Completion
- 2011-02-28
Countries
- United States
Study Locations
More Related Trials
-
Morphological and Serological Criteria of Plaque Vulnerability: Risk Assessment for Symptomatic and Asymptomatic Carotid Artery Stenosis
NCT02124928 ·Status: UNKNOWN
-
Carotid Atherosclerosis Regression at Magnetic Resonance Assessment.
NCT00307307 ·Status: COMPLETED ·Phase: PHASE4
-
The Changes in Carotid Plaque Neovascularization After Elovocumab Therapy
NCT04423406 ·Status: UNKNOWN
-
Single-center, Prospective Cohort Study of PD-1 Inhibitors on Clinical Outcomes of Carotid Plaques in Tumor Patients
NCT05549336 ·Status: UNKNOWN
-
TRACER RGD-K5 Carotid Plaque Imaging Study
NCT01968226 ·Status: TERMINATED ·Phase: PHASE2
-
Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
NCT01178320 ·Status: COMPLETED
-
TRACER [F-18] RDG-K5 Carotid Plaque Imaging Study
NCT03364270 ·Status: COMPLETED ·Phase: PHASE2
-
Accelerated Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging
NCT02114697 ·Status: TERMINATED ·Phase: PHASE4
-
Neuroinflammation in Asymptomatic Carotid Artery Disease - Imaging Substudy
NCT05238961 ·Status: WITHDRAWN ·Phase: PHASE1
-
[F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis
NCT01602471 ·Status: TERMINATED ·Phase: PHASE2
-
Physiopathological and Therapeutic Value of microRNA in the Progression of Carotid Artery Plaques: Carotid Protocol and microRNA
NCT02804659 ·Status: UNKNOWN
-
Comparison of Fimasartan Versus Amlodipine Therapy on Carotid PlaquE Inflammation
NCT02378064 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab
NCT02992301 ·Status: UNKNOWN ·Phase: PHASE4
-
Bacteria in Atherosclerotic Plaques and Adverse Events
NCT06935279 ·Status: COMPLETED
-
Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent Claudication
NCT00117650 ·Status: COMPLETED ·Phase: PHASE2
-
Study Effect of VIA-2291 on Atherosclerotic Vascular Inflammation in Patients Undergoing Elective Carotid Endarterectomy
NCT00352417 ·Status: COMPLETED ·Phase: PHASE2
-
Carnosine for Peripheral Arterial Disease
NCT04870229 ·Status: COMPLETED ·Phase: PHASE2
-
Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease
NCT03304821 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Pactimibe in Patients With Atherosclerosis
NCT00185146 ·Status: COMPLETED ·Phase: PHASE2
-
Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque
NCT00636766 ·Status: COMPLETED ·Phase: NA
-
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
NCT01059682 ·Status: TERMINATED ·Phase: PHASE3
-
Arachidonic Acid Metabolism in Carotid Stenosis Plaque in Diabetic Patients
NCT03202823 ·Status: COMPLETED
-
Investigation of Plaque Instability Using Bevacizumab-800CW and MSOT
NCT03757507 ·Status: UNKNOWN ·Phase: NA
-
Rosiglitazone Plaque Study
NCT00123227 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
NCT03248401 ·Status: COMPLETED ·Phase: PHASE4